Bristol-Myers To Buy Celgene; A $74 Billion Deal
January 03, 2019 at 07:31 AM EST
Bristol-Myers Squibb has struck a deal to buy Celgene in a deal valued at $74 billion in equity and cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.